T1	Participants 31 96	positron emission tomography-negative stage I/II Hodgkin lymphoma
T2	Participants 311 365	patients with clinical stage I/II Hodgkin lymphoma (HL
T3	Participants 666 710	patients attaining a negative early PET scan
T4	Participants 867 946	Patients age 15 to 70 years with untreated clinical stage I/II HL were eligible
T5	Participants 1301 1315	1,137 patients
